CVRx (CVRX) Gross Margin (2020 - 2026)
CVRx's quarterly Gross Margin came in at 87.22% in Q1 2026, up 370.0% year-on-year from 18.56% in Q1 2025, and up 1.09% quarter-over-quarter from 86.28% in Q4 2025.
CVRx has reported Gross Margin for 7 years, with the latest figure at 87.22% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin rose 370.0% year-over-year to 87.22%; the trailing twelve-month figure through Mar 2026 stood at 86.18% (up 274.0% YoY), and the FY2025 full-year result was 85.33%, up 158.0% from the prior year.
- Gross Margin for Q1 2026 stood at 87.22%, up from 86.28% in the prior quarter.
- The five-year high for Gross Margin was 87.22% in Q1 2026, with the low at 76.13% in Q2 2022.
- Average Gross Margin over 5 years is 82.92%, with a median of 83.91% recorded in 2024.
- Year-over-year, Gross Margin jumped 790 bps in 2023 and slumped 154 bps in 2024.
- Tracing CVRX's Gross Margin over 5 years: stood at 78.97% in 2022, then advanced by 7 bps to 84.79% in 2023, then decreased by 2 bps to 83.24% in 2024, then rose by 4 bps to 86.28% in 2025, then climbed by 1 bps to 87.22% in 2026.
- The last three Gross Margin figures came in at 87.22% (Q1 2026), 86.28% (Q4 2025), and 86.81% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 43.89% |
| 10 | CVRx | 144.43 Mn | 72.13 Mn | 12.88 Mn | 87.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87.22% |
| Dec 31, 2025 | 86.28% |
| Sep 30, 2025 | 86.81% |
| Jun 30, 2025 | 84.26% |
| Mar 31, 2025 | 83.51% |
| Dec 31, 2024 | 83.24% |
| Sep 30, 2024 | 83.19% |
| Jun 30, 2024 | 83.91% |
| Mar 31, 2024 | 85.00% |
| Dec 31, 2023 | 84.79% |
| Sep 30, 2023 | 83.91% |
| Jun 30, 2023 | 84.03% |
| Mar 31, 2023 | 83.36% |
| Dec 31, 2022 | 78.97% |
| Sep 30, 2022 | 78.34% |
| Jun 30, 2022 | 76.13% |
| Mar 31, 2022 | 76.72% |
| Dec 31, 2021 | 73.10% |
| Sep 30, 2021 | 74.20% |
| Jun 30, 2021 | 70.77% |
| Mar 31, 2021 | 69.69% |
| Dec 31, 2020 | 78.40% |
| Sep 30, 2020 | 78.74% |
| Jun 30, 2020 | 72.40% |